Dr Reddys Laboratories annual gross margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories's gross margin was 58.50% for fiscal 2025.
View full Dr Reddys Laboratories company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-03-31 | 58.50% | −0.11 pp |
| 2024 | 2024-03-31 | 58.61% | +1.93 pp |
| 2023 | 2023-03-31 | 56.67% | +3.57 pp |
| 2022 | 2022-03-31 | 53.10% | −1.23 pp |
| 2021 | 2021-03-31 | 54.33% | +0.49 pp |
| 2020 | 2020-03-31 | 53.84% | −0.39 pp |
| 2019 | 2019-03-31 | 54.23% | +0.50 pp |
| 2018 | 2018-03-31 | 53.72% | −1.92 pp |
| 2017 | 2017-03-31 | 55.65% | −4.00 pp |
| 2016 | 2016-03-31 | 59.65% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Over the last five reported fiscal years, Dr Reddys Laboratories's gross margin increased from 53.84% to 58.50%, a change of +4.65 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories filings at SEC.gov ↗